RCM Technologies (RCMT) Q1 2026 earnings summary

Executive summary

• Revenue for the quarter ended April 4, 2026, was $83.0 million, down 1.7% year-over-year, with net income of $3.8 million, a 8.2% decrease from the prior year period.

• Specialty Healthcare segment drove growth, offset by declines in Engineering and Life Sciences, Data and Solutions segments.

• Gross profit margin improved slightly to 26.5%, while operating income margin declined to 7.2%.

Financial highlights

• Revenue: $83.0 million (down $1.4 million year-over-year).

• Net income: $3.8 million (down from $4.2 million year-over-year).

• Gross profit: $22.0 million (up slightly from $22.0 million year-over-year).

• Operating income: $5.9 million (down from $6.6 million year-over-year).

• Adjusted EBITDA: $8.1 million (up from $7.8 million year-over-year).

• Diluted EPS: $0.52 (down from $0.54 year-over-year); Adjusted diluted EPS: $0.69 (up from $0.63 year-over-year).

Outlook and guidance

• Management expects continued volatility due to economic cycles and competitive pressures.

• Fiscal discipline and diversification are expected to provide some insulation from adverse trends.